K. Dasse

发表

Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma

P. Novelli, Michael J Lander, K. Dasse, 2016, Journal of the advanced practitioner in oncology.

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.

A. Rosemurgy, D. Wagener, S. Krishnamurthi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.

Lucio Crino, Roger B Cohen, P. Jänne, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.